History of Cyclodextrin Nanosponges.

crosslinked polymer cyclodextrin nanosponge history

Journal

Polymers
ISSN: 2073-4360
Titre abrégé: Polymers (Basel)
Pays: Switzerland
ID NLM: 101545357

Informations de publication

Date de publication:
14 May 2020
Historique:
received: 19 04 2020
revised: 06 05 2020
accepted: 07 05 2020
entrez: 20 5 2020
pubmed: 20 5 2020
medline: 20 5 2020
Statut: epublish

Résumé

Nowadays, research in the field of nanotechnology and nanomedicine has become increasingly predominant, focusing on the manipulation and development of materials on a nanometer scale. Polysaccharides have often been used as they are safe, non-toxic, hydrophilic, biodegradable and are low cost. Among them, starch derivatives and, in particular, cyclodextrin-based nanosponges (CD NSs) have recently emerged due to the outstanding properties attributable to their peculiar structure. In fact, alongside the common polysaccharide features, such as the presence of tunable functional groups and their ability to interact with biological tissues, thus giving rise to bioadhesion, which is particularly useful in drug delivery, what makes CD NSs unique is their three-dimensional network made up of crosslinked cyclodextrin units. The name "nanosponge" appeared for the first time in the 1990s due to their nanoporous, sponge-like structure and responded to the need to overcome the limitations of native cyclodextrins (CDs), particularly their water solubility and inability to encapsulate charged and large molecules efficiently. Since CD NSs were introduced, efforts have been made over the years to understand their mechanism of action and their capability to host molecules with low or high molecular weight, charged, hydrophobic or hydrophilic by changing the type of cyclodextrin, crosslinker and degree of crosslinking used. They enabled great advances to be made in various fields such as agroscience, pharmaceutical, biomedical and biotechnological sectors, and NS research is far from reaching its conclusion. This review gives an overview of CD NS research, focusing on the origin and key points of the historical development in the last 50 years, progressing from relatively simple crosslinked networks in the 1960s to today's multifunctional polymers. The approach adopted in writing the present study consisted in exploring the historical evolution of NSs in order to understand their role today, and imagine their future.

Identifiants

pubmed: 32423091
pii: polym12051122
doi: 10.3390/polym12051122
pmc: PMC7285114
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Pharm Pharm Sci. 2012;15(1):103-11
pubmed: 22365092
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jul;8(4):579-601
pubmed: 26800431
Drug Deliv. 2010 Aug;17(6):419-25
pubmed: 20429848
Drug Dev Ind Pharm. 2015;41(12):2029-36
pubmed: 26006328
Drug Deliv. 2017 Nov;24(1):670-680
pubmed: 28368209
Beilstein J Org Chem. 2014 Nov 19;10:2715-23
pubmed: 25550735
Free Radic Biol Med. 2016 Aug;97:24-37
pubmed: 27184956
J Biomed Nanotechnol. 2016 Jan;12(1):114-27
pubmed: 27301177
Int J Pharm. 2016 Sep 25;511(2):913-20
pubmed: 27473278
Int J Pharm. 2019 Jun 30;565:333-350
pubmed: 31082468
AAPS PharmSciTech. 2011 Mar;12(1):279-86
pubmed: 21240574
Toxins (Basel). 2012 Feb;4(2):98-109
pubmed: 22474569
Colloids Surf B Biointerfaces. 2015 Dec 1;136:105-10
pubmed: 26364091
Adv Drug Deliv Rev. 2002 Jan 17;54(1):149-61
pubmed: 11755710
Cancers (Basel). 2019 Jan 10;11(1):
pubmed: 30634580
Pharm Dev Technol. 2013 May-Jun;18(3):619-25
pubmed: 22235935
Artif Cells Nanomed Biotechnol. 2018 Aug;46(5):1064-1075
pubmed: 28758795
Expert Opin Drug Deliv. 2014 Jun;11(6):931-41
pubmed: 24811423
Carbohydr Polym. 2019 Jun 1;213:70-78
pubmed: 30879691
Phys Chem Chem Phys. 2015 Apr 21;17(15):10274-82
pubmed: 25798878
Pharm Nanotechnol. 2019;7(5):343-361
pubmed: 31549599
Eur J Pharm Biopharm. 2017 Aug;117:276-285
pubmed: 28456606
Polymers (Basel). 2019 Oct 11;11(10):
pubmed: 31614648
Eur J Pharm Sci. 2012 Nov 20;47(4):686-94
pubmed: 22917641
Pak J Pharm Sci. 2018 Sep;31(5(Supplementary)):2069-2076
pubmed: 30393214
Expert Opin Drug Deliv. 2014 Jan;11(1):111-20
pubmed: 24298891
J Mater Sci Mater Med. 2019 Jun 13;30(6):74
pubmed: 31197491
Polymers (Basel). 2018 Feb 22;10(2):
pubmed: 30966247
AAPS PharmSciTech. 2017 Jul;18(5):1728-1738
pubmed: 27757921
Drug Dev Ind Pharm. 2019 Feb;45(2):333-347
pubmed: 30388376
Pharmaceutics. 2019 Oct 20;11(10):
pubmed: 31635183
Pharmaceutics. 2019 Mar 20;11(3):
pubmed: 30897794
Mol Pharm. 2018 Sep 4;15(9):4084-4091
pubmed: 30040427
Chempluschem. 2016 May;81(5):439-443
pubmed: 31968779
J Pharm Sci. 2015 May;104(5):1856-63
pubmed: 25754724
Beilstein J Org Chem. 2017 Jan 27;13:182-194
pubmed: 28228859
Int J Pharm. 2010 Dec 15;402(1-2):254-7
pubmed: 20888402
Molecules. 2018 Jul 11;23(7):
pubmed: 29997364
Dalton Trans. 2009 Sep 7;(33):6507-12
pubmed: 19672496
Drug Dev Ind Pharm. 2017 Dec;43(12):2076-2084
pubmed: 28845699
AAPS PharmSciTech. 2018 Jul;19(5):2358-2369
pubmed: 29869305
Oncotarget. 2018 Nov 9;9(88):35813-35829
pubmed: 30533197
Adv Drug Deliv Rev. 2008 Dec 14;60(15):1650-62
pubmed: 18848591
Carbohydr Polym. 2016 May 20;142:24-30
pubmed: 26917369
J Pharm Sci. 2014 Dec;103(12):3941-3949
pubmed: 25322671
Drug Dev Ind Pharm. 2018 Aug;44(8):1243-1253
pubmed: 29452493
Carbohydr Polym. 2018 Sep 1;195:586-592
pubmed: 29805015
Int J Pharm. 2017 Oct 15;531(2):470-479
pubmed: 28645630
Expert Opin Drug Deliv. 2016 Dec;13(12):1671-1680
pubmed: 27737572
Carbohydr Polym. 2019 Nov 15;224:115168
pubmed: 31472867
Pharmaceutics. 2019 Aug 11;11(8):
pubmed: 31405229
Environ Sci Technol. 2015 Sep 1;49(17):10570-80
pubmed: 26237660
Curr Pharm Des. 2016;22(46):6988-6997
pubmed: 27981908
J Biomater Sci Polym Ed. 2002;13(6):637-49
pubmed: 12182549
Eur J Pharm Biopharm. 2010 Feb;74(2):193-201
pubmed: 19900544
Beilstein J Org Chem. 2012;8:2091-9
pubmed: 23243470
J Biomed Nanotechnol. 2013 Jun;9(6):998-1007
pubmed: 23858964
Int J Pharm. 2013 Nov 1;456(1):95-100
pubmed: 23954237
J Chromatogr A. 2020 Jan 4;1609:460654
pubmed: 31679713
J Colloid Interface Sci. 2019 Nov 15;556:128-139
pubmed: 31437658
Int J Pharm. 2013 Feb 25;443(1-2):262-72
pubmed: 23279938
Int J Nanomedicine. 2019 Jun 24;14:4589-4599
pubmed: 31296988
Curr Drug Deliv. 2011 Mar;8(2):194-202
pubmed: 21235471
Biomed Pharmacother. 2016 Dec;84:485-494
pubmed: 27685792
Int J Pharm. 2015 Oct 15;494(1):244-8
pubmed: 26276257
Carbohydr Polym. 2016 Feb 10;137:339-349
pubmed: 26686138
Food Chem Toxicol. 2019 Oct;132:110647
pubmed: 31260710
Carbohydr Polym. 2018 Jun 15;190:23-30
pubmed: 29628242

Auteurs

Ilona Krabicová (I)

Department of Nanochemistry, Advanced Technologies and Innovation, Technical Institute for Nanomaterials, University of Liberec, Studentská 1402/2, 461 17 Liberec, Czech Republic.

Silvia Lucia Appleton (SL)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.

Maria Tannous (M)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.

Gjylije Hoti (G)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.

Fabrizio Caldera (F)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.

Alberto Rubin Pedrazzo (A)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.

Claudio Cecone (C)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.

Roberta Cavalli (R)

Department of Drug Science and Technology, University of Torino, via P. Giuria 9, 10125 Torino, Italy.

Francesco Trotta (F)

Department of Chemistry, University of Torino, via P. Giuria 7, 10125 Torino, Italy.

Classifications MeSH